Additional file 5 of A randomized, double-blind, placebo-controlled phase II trial to explore the effects of a GABAA-��5 NAM (basmisanil) on intellectual disability associated with Down syndrome

Autor: Goeldner, Celia, Kishnani, Priya S., Skotko, Brian G., Casero, Julian Lirio, Hipp, Joerg F., Derks, Michael, Hernandez, Maria-Clemencia, Khwaja, Omar, Lennon-Chrimes, Sian, Noeldeke, Jana, Pellicer, Sabine, Squassante, Lisa, Visootsak, Jeannie, Wandel, Christoph, Fontoura, Paulo, d���Ardhuy, Xavier Liogier
Rok vydání: 2022
DOI: 10.6084/m9.figshare.19129028.v1
Popis: Additional file 5. Percent of Participants with Relevant Improvements for each Assessment of the Composite Endpoint by Age Group at 3 and 6 months. A table showing percent of participants with above-threshold improvements for each assessment by age group and time point.
Databáze: OpenAIRE